Rohitt Mahajan joins Intuitive as GM in India

IMT News Desk
IMT News Desk
· 2 min read

Mahajan will lead the company’s business strategy and operations

Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced its appointment of Rohitt Mahajan as vice president and general manager for India. Mahajan will lead the company’s business strategy and operations.

“India is poised to be a global leader in minimally invasive care. The combination of innovative surgeons, patient-focused hospitals, and forward-thinking policymakers committed to delivering exceptional care makes India incredibly dynamic and important for Intuitive,” said Intuitive Senior Vice President and President, Asia Pacific, Glenn Vavoso. “Rohitt Mahajan brings deep healthcare experience from India and across Asia, which will enable Intuitive to build stronger partnerships with healthcare providers and positively impact patient care in India.”

Mahajan brings more than 17 years of diverse experience in sales, marketing, strategy, and operations in the healthcare, consumer durables, and IT sectors.  Since joining Intuitive in 2018, he has held key leadership roles, including area sales director for India and director of commercial operations for Asia, where he contributed to the expansion of Intuitive’s commercial operations capabilities and range of global offerings across India and broader Asia region including China, Japan, South Korea, and Taiwan.

“Intuitive India is uniquely positioned to help shape the healthcare landscape in India,” said Mahajan. “I am excited to collaborate with surgeons and executives and lead the Intuitive India team as we expand patient access to robotic-assisted surgery and the benefits it can offer.”

Read Next

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules
News
June 11, 2026

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules

Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Larotrectinib Capsules, 25 mg and 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vitrakvi Capsules, 25 mg and 100 mg, of […]
Article by: IMT News Desk
DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 
News
June 11, 2026

DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 

DFE Pharma has earned its third consecutive Gold Medal from EcoVadis, the world leader in corporate sustainability assessments, in recognition of its strong performance in the four themes rated: Environment, Labor & Human Rights, Ethics and Sustainable Procurement. This distinction places DFE Pharma in the top 5% of companies, reflecting the company’s focused efforts to […]
Article by: IMT News Desk
Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India
News
June 11, 2026

Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India

Oval Advanced Fertility Care and Merck Specialities Private Limited, the Indian healthcare arm of Merck KGaA, Darmstadt, Germany and a global leader in fertility sciences with decades of scientific leadership in reproductive medicine, have signed a strategic Memorandum of Understanding (MOU).   India’s IVF market, valued at approximately USD 2.35 billion in 2024, is projected […]
Article by: IMT News Desk
Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global
News
June 11, 2026

Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global

Bengaluru-based precision oncology startup 4baseCare has raised ₹128 crore in its ongoing Series B funding round to expand its hospital-linked genomics laboratory network globally and scale its AI-powered precision oncology platform, OncoTwin. The latest funding round, which follows a first close of ₹90 crore co-led by Ashish Kacholia and Lashit Sanghvi with participation from existing […]
Article by: IMT News Desk